Antiviral Drugs Market to Increase to US$82.9 Bn by 2024
TMR has envisaged the global antiviral drugs market to garner a whopping revenue of US$82.9 bn by the concluding forecast year at a 6.40% CAGR. In 2015, there had been a valuation of US$48.3 bn achieved by the market. In terms of disease indication, HIV infection could showcase its prominence in the market as there have been reports of its rising prevalence. Earning an over 50.0% share of the market in 2015, North America has been prophesied to continue overpowering...
View full press release